POLA-R-CHP Clinical Trials
3 recruitingDrug
Phase 22
Showing 1–3 of 3 trials
Recruiting
Phase 2
Genetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation
Diffuse Large B-Cell Lymphoma (DLBCL)
The First Affiliated Hospital of Soochow University35 enrolled1 locationNCT07499271
Recruiting
Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET
Fudan University300 enrolled1 locationNCT07070648
Recruiting
Phase 2
POLA-R-CHP in the First-line Treatment of Transformed DLBCL
Transformed Lymphoma
Fudan University20 enrolled1 locationNCT06743945